Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

The Journal of Asthma and Allergy, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing research in the fields of immunology, allergy, and pulmonary medicine. Since its inception in 2008, this journal has provided a vital platform for disseminating high-quality, peer-reviewed research that explores the complexities of asthma and allergy, allowing researchers, professionals, and students to access critical insights without subscription barriers. With an impressive impact factor reflected in its 2023 quartile rankings (Q2) in both Immunology and Allergy, as well as Pulmonary and Respiratory Medicine, the journal stands as a significant contributor to the scientific community, promoting innovative findings that support clinical practice and patient care. Based in New Zealand, the Journal of Asthma and Allergy continues to be at the forefront of research, from its dedication to publishing cutting-edge studies to fostering an inclusive academic discourse that spans the globe. Access to relevant articles is available online, ensuring that all stakeholders in these fields can stay informed and engaged.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on the dynamic fields of immunology and allergy. With an ISSN of 0889-8561 and an E-ISSN of 1557-8607, this journal has consistently ranked in the Q2 category in both Immunology and Immunology and Allergy as per 2023 metrics, underscoring its critical role in academia. It provides cutting-edge research, comprehensive reviews, and practical insights that cater to the needs of researchers, clinicians, and students alike. Though the journal is not open access, it remains an essential resource for those involved in advancing knowledge and clinical practice in allergy and immunology. With its converged years stretching from 1987 to 2024, the journal serves as a rich repository of scientific advancements, fostering progress in diagnosis, treatment, and prevention of allergic diseases and immune disorders. Positioned within the United States and based in Philadelphia, it plays a vital role in promoting scholarly communication within these impactful fields.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.

ALLERGOLOGY INTERNATIONAL is a prestigious, peer-reviewed journal dedicated to advancing the field of immunology and allergy research. Published by the Japanese Society of Allergology, this Open Access journal has been democratizing knowledge since 1996, providing a platform for the latest findings and clinical practices in the management of allergic diseases. Its impressive Q1 ranking in both Immunology and Allergy** and **Medicine (miscellaneous)** categories in 2023 highlights its significance in the global scientific community, with a commendable Scopus ranking of #31 out of 233 in the field of immunology. The journal's focus on innovative research, comprehensive reviews, and case studies ensures that it remains a vital resource for researchers, healthcare professionals, and students alike. Situated in Tokyo, Japan, it continues to bridge gaps in allergy-related health information and foster international collaboration among scholars.

The Revue Francaise d'Allergologie, an esteemed publication in the field of Immunology and Allergy, is published by ELSEVIER MASSON, CORP OFF in France. This journal plays a pivotal role in disseminating significant findings and advancements in allergy research and immunotherapy, reflecting the latest trends and challenges in these rapidly evolving areas. As part of its commitment to scholarly rigor, the journal encompasses a wide range of topics pertinent to allergology, aiming to bridge the gap between clinical practice and academic research. Although currently not listed as open access, it provides critical insights essential for researchers, professionals, and students alike, ensuring the advancement of knowledge and therapeutic strategies in allergy and immunology. With its impact factor and positioning in the Q4 category, it serves as a valuable resource, aiding in the education and development of future leaders in the field. The Revue Francaise d'Allergologie continues to be a vital platform for the exchange of innovative ideas and findings from 2009 to the present.

Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.

Current Allergy & Clinical Immunology is a vital peer-reviewed journal published by the Allergy Society of South Africa, focused on advancing the field of immunology and allergy medicine. With an ISSN of 1609-3607, this journal offers crucial insights and research findings pertinent to the understanding and treatment of allergic conditions. Operating from South Africa, it features contributions from a diverse range of authors and professionals in the field. Published from 2008 to 2024, the journal plays an essential role in disseminating current knowledge, even as it holds a Q4 ranking in Immunology and Allergy and is positioned at the 4th percentile based on Scopus rankings. While not open access, it remains an important resource for researchers, practitioners, and students looking to stay informed on emerging trends and breakthroughs in allergy and clinical immunology.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

World Allergy Organization Journal is a premier open-access publication dedicated to advancing the understanding and treatment of allergic diseases and related conditions. Published by ELSEVIER, this journal boasts a commendable impact factor and ranks in the second quartile for both Immunology and Allergy, as well as the first quartile in Pulmonary and Respiratory Medicine. Since its inception as an open-access journal in 2008, it has consistently aimed to provide a credible platform for researchers, clinicians, and students to disseminate original research, reviews, and clinical studies. With its emphasis on high-quality scholarship and practical applications, the World Allergy Organization Journal plays a crucial role in bridging theoretical knowledge with clinical practice, making significant contributions to the fields of immunology, allergy, and respiratory medicine. The journal is particularly notable for its accessibility to a global audience, exemplified by its open-access model since 2008, promoting a wider exchange of ideas and innovations across borders.